SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (12910)8/8/1998 3:41:00 AM
From: Stephen O'Hara  Read Replies (1) of 23519
 
Thanks for the update BK,

I've only heard of 1 or 2 on that list. That could be an opportunity for the stock price to spike, if Fidelity or any other Fund found Vivus at all appealing. Right now the only one that I think might have an interest would be Franklin, because they love beaten-up stocks. (They call it value stocks, I think we would all called it "Erectile Deficient" Stocks)

For example, they were all over Oxford Health last spring, and when the news got out in Barrons, OXHP went from 13 to 22. I think anyone would have to say that VVUS is a value play, UNLESS you think that they will fold. I think that in this day & age a merger or buyout normally heads off bankruptcy.

Thanks again,

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News